Vimarsana
Biggest News Aggregation in the World

Page 6 - Clinical Practice News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Practice. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Practice Today - Breaking & Trending Today

Many Ears Make Light Listening - Vimarsana News

Many Ears Make Light Listening

When we share our stories publicly, whether in speaking, writing, or another art form, we acknowledge we are part of something bigger. We are aware we aren't the only ones who have been abused or witnessed abuse, or who are scared to let go of our ancestral shame and fear. We are, rather, part of an entire generation, an entire society that is moving away from silence, blame and abuse. In sharing our stories, we instantly recover from a big hunk of loneliness, loneliness that might not be so easily resolved sitting in a room across from a professional, with a few non-offensive art pieces ...

ACC.24: Smidt Heart Institute Experts to Share Research Findings, Clinical Knowledge - Vimarsana News

ACC.24: Smidt Heart Institute Experts to Share Research Findings, Clinical Knowledge

Leading Expert in Sudden Cardiac Arrest, Sumeet Chugh, MD, to Be Presented American College of Cardiology Distinguished Scientist Award

New Novartis data show early addition of twice-yearly* - Vimarsana News

New Novartis data show early addition of twice-yearly*

V-INITIATE trial demonstrates that early initiation with Leqvio, prior to guideline-recommended ezetimibe, for ASCVD patients unable to achieve LDL-C goal...

New Novartis data show early addition of twice-yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting - Vimarsana News

New Novartis data show early addition of twice-yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting

V-INITIATE trial demonstrates that early initiation with Leqvio, prior to guideline-recommended ezetimibe, for ASCVD patients unable to achieve LDL-C goal on...

Expert Perspectives - Florida Tech News - Vimarsana News

Expert Perspectives - Florida Tech News

A compilation of recent College of Psychology and Liberal Arts faculty presentations and publications

Source: fit.edu